148 related articles for article (PubMed ID: 30154846)
1. The Association of Simultaneous Increase in Interleukin-6, C Reactive Protein, and Matrix Metalloproteinase-9 Serum Levels with Increasing Stages of Colorectal Cancer.
Rasic I; Rebic V; Rasic A; Aksamija G; Radovic S
J Oncol; 2018; 2018():2830503. PubMed ID: 30154846
[TBL] [Abstract][Full Text] [Related]
2. Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.
Biasi F; Guina T; Maina M; Nano M; Falcone A; Aroasio E; Saracco GM; Papotti M; Leonarduzzi G; Poli G
PLoS One; 2012; 7(7):e41839. PubMed ID: 22848630
[TBL] [Abstract][Full Text] [Related]
3. Correlation of interleukin-6 and C-reactive protein levels in plasma with the stage and differentiation of colorectal cancer: A cross-sectional study in East Indonesia.
Hidayat F; Labeda I; Sampetoding S; Pattelongi IJ; Lusikooy RE; Warsinggih ; Dani MI; Mappincara ; Kusuma MI; Uwuratuw JA; Syarifuddin E; Faruk M
Ann Med Surg (Lond); 2021 Feb; 62():334-340. PubMed ID: 33552492
[TBL] [Abstract][Full Text] [Related]
4. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
Sirniö P; Tuomisto A; Tervahartiala T; Sorsa T; Klintrup K; Karhu T; Herzig KH; Mäkelä J; Karttunen TJ; Salo T; Mäkinen MJ; Väyrynen JP
Br J Cancer; 2018 Jul; 119(2):213-219. PubMed ID: 29808017
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
6. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
[TBL] [Abstract][Full Text] [Related]
7. Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels.
Preston GA; Barrett CV; Alcorta DA; Hogan SL; Dinwiddie L; Jennette JC; Falk RJ
Nephron; 2002 Dec; 92(4):817-23. PubMed ID: 12399626
[TBL] [Abstract][Full Text] [Related]
8. Elevated Serum Matrix Metalloproteinase-9, Interleukin-6, Hypersensitive C-Reactive Protein, and Homocysteine Levels in Patients with Epilepsy.
Tao H; Gong Y; Yu Q; Zhou H; Liu Y
J Interferon Cytokine Res; 2020 Mar; 40(3):152-158. PubMed ID: 31971845
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Mroczko B; Groblewska M; Okulczyk B; Kedra B; Szmitkowski M
Int J Colorectal Dis; 2010 Oct; 25(10):1177-84. PubMed ID: 20556397
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer.
Chang PH; Pan YP; Fan CW; Tseng WK; Huang JS; Wu TH; Chou WC; Wang CH; Yeh KY
Cancer Med; 2016 Mar; 5(3):426-33. PubMed ID: 26799163
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.
Tedeschi A; Asero R; Lorini M; Marzano AV; Cugno M
Clin Exp Allergy; 2010 Jun; 40(6):875-81. PubMed ID: 20214668
[TBL] [Abstract][Full Text] [Related]
13. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
[TBL] [Abstract][Full Text] [Related]
14. Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients.
Farsad-Naeimi A; Alizadeh M; Esfahani A; Darvish Aminabad E
Food Funct; 2018 Apr; 9(4):2025-2031. PubMed ID: 29541713
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the acute systemic and tissue inflammatory response following carotid endarterectomy.
Gabrile SA; Antonangelo L; Capelozzi VR; Beteli CB; DE Camargo O; Braga DE Aquino JL; Caffaro RA
Int Angiol; 2016 Apr; 35(2):148-56. PubMed ID: 25994448
[TBL] [Abstract][Full Text] [Related]
16. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.
Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H
Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.
Nikiteas NI; Tzanakis N; Gazouli M; Rallis G; Daniilidis K; Theodoropoulos G; Kostakis A; Peros G
World J Gastroenterol; 2005 Mar; 11(11):1639-43. PubMed ID: 15786541
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
Lumachi F; Basso SM; Santeufemia DA; Ermani M; Lo Re G; Chiara GB
Anticancer Res; 2014 Dec; 34(12):7263-6. PubMed ID: 25503158
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients.
Shiga K; Hara M; Nagasaki T; Sato T; Takahashi H; Sato M; Takeyama H
Gastroenterol Res Pract; 2016; 2016():9701574. PubMed ID: 26858756
[TBL] [Abstract][Full Text] [Related]
20. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
Kanoh Y; Abe T; Masuda N; Akahoshi T
Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
